---
title: "Major Investor Quietly Unloads a Massive Chunk of Aditxt Stock"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290900945.md"
description: "Takeover Time 2026 LLC sold 3.42 million Aditxt shares on June 25, 2026, valued at $68,408. This exit occurs as Aditxt faces Nasdaq delisting orders due to bid price failures and negative equity. The company's stock has plummeted nearly 100% year-to-date, with a market cap of just $34K, amid concerns over dilutive financing and execution risks."
datetime: "2026-06-26T02:04:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290900945.md)
  - [en](https://longbridge.com/en/news/290900945.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290900945.md)
generator: "portal-rs"
---

# Major Investor Quietly Unloads a Massive Chunk of Aditxt Stock

New insider activity at Aditxt ( (ADTX) ) has taken place on June 25, 2026.

Significant shareholder Takeover Time 2026 LLC has reduced its position in Aditxt, exiting a sizeable block of 3,420,439 shares. The transaction, valued at $68,408, marks a notable move in Aditxt’s shareholder activity and may signal a shift in how major investors are positioning themselves around the stock.

Aditxt’s stock has been pressured after a Nasdaq Hearings Panel ordered its delisting, citing chronic minimum bid price failures, deeply negative equity, repeated reverse splits, and ongoing $5M quarterly losses, while doubting that a proposed $150M SPAC spin-off of Ignite Proteomics would deliver durable compliance. Sentiment is further weighed down by highly dilutive, secured convertible note financings that pledge nearly all Ignite assets and expand leverage, signaling strained capital structure and execution risk.

**More about Aditxt**

**YTD Price Performance:** -99.98%

**Average Trading Volume:** 125,540,746

**Technical Sentiment Signal:** Strong Sell

**Current Market Cap:** $34.02K

### Related Stocks

- [ADTX.US](https://longbridge.com/en/quote/ADTX.US.md)

## Related News & Research

- [Aditxt sells majority stake in Pearsanta to MDNA Holdings](https://longbridge.com/en/news/296397614.md)
- [Aditxt Amends Note Purchase Pact to Add Investor, Swap Notes With No Change in Principal](https://longbridge.com/en/news/293058989.md)
- [BEST SPAC I Acquisition Disclosed Failure to Satisfy a Continued Listing Rule or Standard](https://longbridge.com/en/news/296902509.md)
- [Best SPAC I Acquisition flags Nasdaq listing deficiency after market value falls below $35 million minimum](https://longbridge.com/en/news/296901910.md)
- [The9 expects 15%-16% stake in Nanyang Biologics after planned Nasdaq SPAC merger](https://longbridge.com/en/news/296618346.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**